By Matt Hicks
This article is the second of a two-part article discussing the unique value proposition of used pharmaceutical manufacturing equipment. All manufacturing organizations need to responsibly manage assets, but pharmaceutical equipment requires unique strategies to manage and recapture its value.
Investment Recovery for Pharma Equipment,” the first of two-part article, can be read in its entirety here. This is a short synopsis of Part I, which discussed the various affects that both mergers and acquisitions, and an ever-changing product mix, have on pharmaceutical companies. Often the result is two distinct challenges — one is managing surplus inventory, and the second is managing an effective capital equipment investment recovery strategy that addresses the surplus inventory challenge.
There are a number of best practices for viable equipment investment recovery strategies. The first half of this article introduced us to five investment recovery practices for a pharmaceutical manufacturer to consider.